ReviewEinstein (Sao Paulo, Brazil)2026
Bacteria-induced immunity: from homeostasis to immune subversion in periodontitis.
Review in Einstein (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review synthesizes current evidence on host immune responses to bacteria, their roles in the development and progression of periodontitis, and emerging immunomodulatory therapeutic strategies designed to restore periodontal homeostasis. Periodontitis develops through interactions between a dysbiotic bacterial community that disrupts host-microbe homeostasis and a chronic, maladaptive interaction with the host immune system. Key immune subversion microorganisms such as Porphyromonas gingivalis trigger inflammation while subverting immune surveillance by evading complement-mediated clearance and impairing neutrophil function. This dual behavior creates a biological paradox: bacteria induce inflammation to obtain nutrients while simultaneously suppressing effective antimicrobial activity, thereby perpetuating chronic, tissue-destructive immune activation. The osteoimmune response, particularly the Th17/IL-17 axis, is a central pathway linking microbial dysbiosis to persistent inflammation and alveolar bone resorption. These findings suggest that successful periodontal therapy must extend beyond mechanical biofilm removal by addressing underlying immune dysregulation. Potential adjunctive strategies for modulating this response include specialized pro-resolving mediators, complement inhibitors such as Cp40, and selected probiotics with immunoregulatory properties. Collectively, these approaches are intended to restore immune balance, enhance resolution of inflammation, and promote periodontal tissue repair. Current evidence demonstrates that periodontitis is not solely a microbial infection but also involves dysregulated host immunity. Clarifying how bacteria manipulate immune pathways may facilitate the development of therapies that complement bacterial control by targeting the inflammatory mechanisms underlying tissue destruction. Immunomodulatory interventions therefore represent promising candidates for promoting sustained periodontal stability and inflammatory resolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.